COc1ccccc1NC(=O)Cn1c(=O)n(Cc2nc(C)no2)c(=O)c2cc3c(cc21)OCO3
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?